Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells

Tseng,Yu-Hsin; Yang,Rei-Cheng; Chiou,Shyh-Shin; Shieh,Tzong-Ming; Shih,Yin-Hwa; Lin,Pei-Chin

doi:10.3892/mmr.2021.12204

Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells

Authors:
- Yu-Hsin Tseng
- Rei-Cheng Yang
- Shyh-Shin Chiou
- Tzong-Ming Shieh
- Yin-Hwa Shih
- Pei-Chin Lin
View Affiliations

Affiliations: Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan, R.O.C., School of Dentistry, College of Dentistry, China Medical University, Taichung 40402, Taiwan, R.O.C., Department of Healthcare Administration, Asia University, Taichung 41354, Taiwan, R.O.C.
Published online on: June 7, 2021 https://doi.org/10.3892/mmr.2021.12204
Article Number: 565
Copyright: © Tseng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cytarabine is a key chemotherapy drug for treating leukemia; however, chemotherapy‑induced multidrug resistance is a major cause of therapy failure or tumor recurrence. Current medical treatment strategies still cannot address the issue of multidrug resistance phenotypes in the treatment of leukemia. Curcumin counteracts tumor development by inducing apoptosis in cytarabine‑resistant acute myeloid leukemia cells. Branched‑chain amino acid transaminase 1 (BCAT1), an aminotransferase enzyme, acts on branched‑chain amino acids. Moreover, the aberrant expression of BCAT1 has been observed in numerous cancer cells, and BCAT1 serves a critical role in the progression of myeloid leukemia. BCAT1 can interfere with cancer cell proliferation by regulating mTOR‑mediated mitochondrial biogenesis and function. The present study aimed to investigate whether curcumin induces apoptosis by regulating BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells. Four leukemia cell lines and three primary myeloid leukemia cells were treated with curcumin, and the expression and activity of BCAT1 and mTOR were investigated by reverse transcription‑quantitative PCR, western blotting and α‑KG quantification assay. The results demonstrated that curcumin inhibited BCAT1 expression in Kasumi‑1, KG‑1, HL60, cytarabine‑resistant HL60, and cytarabine‑resistant primary myeloid leukemia cells. Notably, tetrahydrocurcumin, a major metabolite of curcumin, and cytarabine had no inhibitory effect on BCAT1 expression. Furthermore, BCAT1 and mTOR signaling may modulate each other in cytarabine‑resistant HL60 cells. The present results indicated that curcumin may induce apoptosis by inhibiting the BCAT1 and mTOR pathways. Thus, understanding the mechanism underlying curcumin‑induced apoptosis in cytarabine‑resistant cells can support the development of novel drugs for leukemia.

View Figures

View References

1	Madhusoodhan PP, Carroll WL and Bhatla T: Progress and prospects in pediatric leukemia. Curr Probl Pediatr Adolesc Health Care. 46:229–241. 2016. View Article : Google Scholar : PubMed/NCBI
2	Lyengar V and Shimanovsky A: Leukemia. StatPearls StatPearls Publishing Copyright © 2021. StatPearls Publishing LLC.; Treasure Island, FL: 2021
3	Liu N, Wang C, Wang L, Gao L, Cheng H, Tang G, Hu X and Wang J: Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis. Int J Mol Med. 37:1686–1696. 2016. View Article : Google Scholar : PubMed/NCBI
4	Tseng YH, Chiou SS, Weng JP and Lin PC: Curcumin and tetrahydrocurcumin induce cell death in Ara-C-resistant acute myeloid leukemia. Phytother Res. 33:1199–1207. 2019. View Article : Google Scholar : PubMed/NCBI
5	Lee TY and Tseng YH: The potential of phytochemicals in oral cancer prevention and therapy: A review of the evidence. Biomolecules. 10:11502020. View Article : Google Scholar : PubMed/NCBI
6	Kouhpeikar H, Butler AE, Bamian F, Barreto GE, Majeed M and Sahebkar A: Curcumin as a therapeutic agent in leukemia. J Cell Physiol. 234:12404–12414. 2019. View Article : Google Scholar : PubMed/NCBI
7	Song X, Zhang M, Dai E and Luo Y: Molecular targets of curcumin in breast cancer (Review). Mol Med Rep. 19:23–29. 2019.PubMed/NCBI
8	Holeček M: Branched-chain amino acids in health and disease: Metabolism, alterations in blood plasma, and as supplements. Nutr Metab (Lond). 15:332018. View Article : Google Scholar
9	Neinast M, Murashige D and Arany Z: Branched chain amino acids. Annu Rev Physiol. 81:139–164. 2019. View Article : Google Scholar : PubMed/NCBI
10	Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP, Yuan C, Bao Y, Townsend MK, Tworoger SS, et al: Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 20:1193–1198. 2014. View Article : Google Scholar : PubMed/NCBI
11	Watanabe A, Higashi T, Sakata T and Nagashima H: Serum amino acid levels in patients with hepatocellular carcinoma. Cancer. 54:1875–1882. 1984. View Article : Google Scholar : PubMed/NCBI
12	Li Z and Zhang H: Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 73:377–392. 2016. View Article : Google Scholar : PubMed/NCBI
13	Sun H, Zhou Y, Skaro MF, Wu Y, Qu Z, Mao F, Zhao S and Xu Y: Metabolic reprogramming in cancer is induced to increase proton production. Cancer Res. 80:1143–1155. 2020. View Article : Google Scholar : PubMed/NCBI
14	DeBerardinis RJ and Chandel NS: Fundamentals of cancer metabolism. Sci Adv. 2:e16002002016. View Article : Google Scholar : PubMed/NCBI
15	Zeng B, Zhang X, Zhao J, Wei Z, Zhu H, Fu M, Zou D, Feng Y, Luo H and Lei Y: The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma. BMC Cancer. 19:6092019. View Article : Google Scholar : PubMed/NCBI
16	Xu Y, Yu W, Yang T, Zhang M, Liang C, Cai X and Shao Q: Overexpression of BCAT1 is a prognostic marker in gastric cancer. Human Pathol. 75:41–46. 2018. View Article : Google Scholar : PubMed/NCBI
17	Zhang L and Han J: Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function. Biochem Biophys Res Commun. 486:224–231. 2017. View Article : Google Scholar : PubMed/NCBI
18	Zheng YH, Hu WJ, Chen BC, Grahn TH, Zhao YR, Bao HL, Zhu YF and Zhang QY: BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin. Liver Int. 36:1836–1847. 2016. View Article : Google Scholar : PubMed/NCBI
19	Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, Tayyari F, McSkimming D, Kannan N, Tojo A, et al: Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 545:500–504. 2017. View Article : Google Scholar : PubMed/NCBI
20	Raffel S, Falcone M, Kneisel N, Hansson J, Wang W, Lutz C, Bullinger L, Poschet G, Nonnenmacher Y, Barnert A, et al: BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature. 551:384–388. 2017. View Article : Google Scholar : PubMed/NCBI
21	Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AHC, Karra D, Piro RM, et al: BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med. 19:901–908. 2013. View Article : Google Scholar
22	Fox DB and Alvarez JV: Epithelial-to-mesenchymal transition activates Bcat1 expression to promote recurrent tumor growth. bioRxiv. Dec 9–2020.(Epub ahead of print). doi: 10.1101/2020.12.08.416479.
23	Gu Z, Liu Y, Cai F, Patrick M, Zmajkovic J, Cao H, Zhang Y, Tasdogan A, Chen M, Qi L, et al: Loss of EZH2 reprograms BCAA metabolism to drive leukemic transformation. Cancer Discov. 9:1228–1247. 2019. View Article : Google Scholar : PubMed/NCBI
24	Chiarini F, Evangelisti C, McCubrey JA and Martelli AM: Current treatment strategies for inhibiting mTOR in cancer. Trends Pharmacol Sci. 36:124–135. 2015. View Article : Google Scholar : PubMed/NCBI
25	Cargnello M, Tcherkezian J and Roux PP: The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis. 30:169–176. 2015. View Article : Google Scholar : PubMed/NCBI
26	Villar VH, Nguyen TL, Delcroix V, Terés S, Bouchecareilh M, Salin B, Bodineau C, Vacher P, Priault M, Soubeyran P and Durán RV: mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nat Commun. 8:141242017. View Article : Google Scholar : PubMed/NCBI
27	Tamaddoni A, Mohammadi E, Sedaghat F, Qujeq D and As'Habi A: The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1(mTORC1) signaling pathway. Pharmacol Res. 156:1047982020. View Article : Google Scholar : PubMed/NCBI
28	Tan HK, Moad AI and Tan ML: The mTOR signalling pathway in cancer and the potential mTOR inhibitory activities of natural phytochemicals. Asian Pac J Cancer Prev. 15:6463–6475. 2014. View Article : Google Scholar : PubMed/NCBI
29	Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R and Jain P: Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit Rev Food Sci Nutr. 60:887–939. 2020. View Article : Google Scholar : PubMed/NCBI
30	Pösel C, Möller K, Fröhlich W, Schulz I, Boltze J and Wagner DC: Density gradient centrifugation compromises bone marrow mononuclear cell yield. PLoS One. 7:e502932012. View Article : Google Scholar
31	Arber DA and Erba HP: Diagnosis and treatment of patients with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC). Am J Clin Pathol. 154:731–741. 2020. View Article : Google Scholar : PubMed/NCBI
32	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
33	Su PF and Song SQ: Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity. Eur Rev Med Pharmacol Sci. 22:6864–6872. 2018.PubMed/NCBI
34	Murugan AK: mTOR: Role in cancer, metastasis and drug resistance. Semin Cancer Biol. 59:92–111. 2019. View Article : Google Scholar : PubMed/NCBI
35	Watson JL, Hill R, Lee PW, Giacomantonio CA and Hoskin DW: Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner. Exp Mol Pathol. 84:230–233. 2008. View Article : Google Scholar : PubMed/NCBI
36	Mishra D, Singh S and Narayan G: Curcumin induces apoptosis in Pre-B acute lymphoblastic leukemia cell lines via PARP-1 cleavage. Asian Pac J Cancer Prev. 17:3865–3869. 2016.PubMed/NCBI
37	Zou Z, Tao T, Li H and Zhu X: mTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges. Cell Biosci. 10:312020. View Article : Google Scholar : PubMed/NCBI
38	Eden A and Benvenisty N: Involvement of branched-chain amino acid aminotransferase (Bcat1/Eca39) in apoptosis. FEBS Lett. 457:255–261. 1999. View Article : Google Scholar : PubMed/NCBI
39	Rozengurt E, Soares HP and Sinnet-Smith J: Suppression of feedback loops mediated by PI3K/mTOR induces multiple overactivation of compensatory pathways: An unintended consequence leading to drug resistance. Mol Cancer Ther. 13:2477–2488. 2014. View Article : Google Scholar : PubMed/NCBI
40	Tian T, Li X and Zhang J: mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy. Int J Mol Sci. 20:7552019. View Article : Google Scholar : PubMed/NCBI
41	Wang Y, Zhang J, Ren S, Sun D, Huang HY, Wang H, Jin Y, Li F, Zheng C, Yang L, et al: Branched-chain amino acid metabolic reprogramming orchestrates drug resistance to EGFR tyrosine kinase inhibitors. Cell Rep. 28:512–525.e6. 2019. View Article : Google Scholar : PubMed/NCBI
42	Gan L, Li C, Wang J and Guo X: Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model. Int J Chron Obstruct Pulmon Dis. 11:2765–2773. 2016. View Article : Google Scholar : PubMed/NCBI
43	Yan X, Pan B, Lv T, Liu L, Zhu J, Shen W, Huang X and Tian J: Inhibition of histone acetylation by curcumin reduces alcohol-induced fetal cardiac apoptosis. J Biomed Sci. 24:12017. View Article : Google Scholar : PubMed/NCBI
44	Laribee RN and Weisman R: Nuclear functions of TOR: Impact on transcription and the epigenome. Genes (Basel). 11:6412020. View Article : Google Scholar : PubMed/NCBI
45	Viscarra JA, Wang Y, Nguyen HP, Choi YG and Sul HS: Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis. Nat Commun. 11:7962020. View Article : Google Scholar : PubMed/NCBI